Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
quote
ASND – Ascendis Pharma A/S –
ASND – Ascendis Pharma A/S –
Quotes
Charts
News & Analysis for ASND
Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $133.00 by Canaccord...
ME Staff
-
April 5, 2019
0
Ascendis Pharma A/S (NASDAQ:ASND) has coverage initiated with a Outperform ➝...
ME Staff
-
March 25, 2019
0
Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush...
ME Staff
-
March 7, 2019
0
Ascendis Pharma A/S (NASDAQ:ASND) had its Buy rating reiterated by HC...
ME Staff
-
February 7, 2019
0
Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $86.00 by Credit...
ME Staff
-
November 29, 2018
0
Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wells...
ME Staff
-
August 30, 2018
0
Analyst Activity – Leerink Swann Reiterates Market Perform on NASDAQ:ASND –...
ME Staff
-
May 31, 2018
0
Analyst Activity – Wedbush Reiterates Outperform on NASDAQ:ASND – Ascendis Pharma...
ME Staff
-
May 15, 2018
0
Analyst Activity – Wedbush Reiterates Top Pick on NASDAQ:ASND – Ascendis...
ME Staff
-
April 20, 2018
0
Analyst Activity – Leerink Swann Raises Its Price Target On ASND...
ME Staff
-
April 2, 2018
0
Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target...
ME Staff
-
March 21, 2018
0
Analyst Activity – Credit Suisse Group Raises Its Price Target On...
ME Staff
-
March 20, 2018
0
Analyst Activity – Credit Suisse Group Reiterates Hold on Ascendis Pharma...
ME Staff
-
March 20, 2018
0
Analyst Activity – Wedbush Reiterates Outperform on Ascendis Pharma A/S (NASDAQ:ASND)
ME Staff
-
February 6, 2018
0
Analyst Activity – Bank of America Raises Its Price Target On...
ME Staff
-
January 25, 2018
0
Analyst Activity – Bank of America Corporation Reiterates Buy on Ascendis...
ME Staff
-
September 25, 2017
0
Ascendis Pharma A/S (NASDAQ:ASND) reported earnings of ($1.04) per share missing...
ME Staff
-
August 19, 2017
0
Ascendis Pharma A/S (NASDAQ:ASND) reported earnings of ($1.10) per share missing...
ME Staff
-
August 18, 2017
0